Related references
Note: Only part of the references are listed.Temporal hemodynamic and histological progression in Sugen5416/hypoxia/normoxia-exposed pulmonary arterial hypertensive rats
Michie Toba et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2014)
Impact of S-Adenosylmethionine Decarboxylase 1 on Pulmonary Vascular Remodeling
Friederike Christine Weisel et al.
CIRCULATION (2014)
Id proteins are critical downstream effectors of BMP signaling in human pulmonary arterial smooth muscle cells
Jun Yang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2013)
Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension Results of the Randomized IMPRES Study
Marius M. Hoeper et al.
CIRCULATION (2013)
Metabolic Gene Remodeling and Mitochondrial Dysfunction in Failing Right Ventricular Hypertrophy Secondary to Pulmonary Arterial Hypertension
Jose Gomez-Arroyo et al.
CIRCULATION-HEART FAILURE (2013)
The Role of Inflammation and Autoimmunity in the Pathophysiology of Pulmonary Arterial Hypertension
Nada Kherbeck et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2013)
Effects of multikinase inhibitors on pressure overload-induced right ventricular remodeling
Baktybek Kojonazarov et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate
Lin Piao et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
FOXOs: signalling integrators for homeostasis maintenance
Astrid Eijkelenboom et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
The Potential Efficacy of R8-Modified Paclitaxel-Loaded Liposomes on Pulmonary Arterial Hypertension
Yujia Yin et al.
PHARMACEUTICAL RESEARCH (2013)
Targeting Energetic Metabolism A New Frontier in the Pathogenesis and Treatment of Pulmonary Hypertension
Rubin M. Tuder et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Inhibition of MicroRNA-17 Improves Lung and Heart Function in Experimental Pulmonary Hypertension
Soni S. Pullamsetti et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Modern Age Pathology of Pulmonary Arterial Hypertension
Elvira Stacher et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Immune and Inflammatory Cell Involvement in the Pathology of Idiopathic Pulmonary Arterial Hypertension
Rajkumar Savai et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Role of Src Tyrosine Kinases in Experimental Pulmonary Hypertension
Soni Savai Pullamsetti et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Circulating Myeloid-Derived Suppressor Cells Are Increased and Activated in Pulmonary Hypertension
Michael E. Yeager et al.
CHEST (2012)
Inflammation in Pulmonary Arterial Hypertension
Laura C. Price et al.
CHEST (2012)
An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry
Raymond L. Benza et al.
CHEST (2012)
FOXOs and Sirtuins in Vascular Growth, Maintenance, and Aging
Mark F. Oellerich et al.
CIRCULATION RESEARCH (2012)
Molecular pathogenesis of pulmonary arterial hypertension
Marlene Rabinovitch
JOURNAL OF CLINICAL INVESTIGATION (2012)
International, Randomized, Placebo-Controlled, Double-Blind Phase III Study of Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer: MONET1
Giorgio V. Scagliotti et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Drug-Eluting Balloon for Treatment of Superficial Femoral Artery In-Stent Restenosis
Eugenio Stabile et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
The Soluble Guanylate Cyclase Stimulator Riociguat Ameliorates Pulmonary Hypertension Induced by Hypoxia and SU5416 in Rats
Michaela Lang et al.
PLOS ONE (2012)
A novel function of FoxO transcription factors in thrombin-stimulated vascular smooth muscle cell proliferation
Shailaja G. Mahajan et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Neutrophil Elastase Is Produced by Pulmonary Artery Smooth Muscle Cells and Is Linked to Neointimal Lesions
Yu-Mee Kim et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Autocrine Fibroblast Growth Factor-2 Signaling Contributes to Altered Endothelial Phenotype in Pulmonary Hypertension
Ly Tu et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2011)
cAMP Phosphodiesterase Inhibitors Increases Nitric Oxide Production by Modulating Dimethylarginine Dimethylaminohydrolases
Soni Savai Pullamsetti et al.
CIRCULATION (2011)
Mechanisms of disease: pulmonary arterial hypertension
Ralph T. Schermuly et al.
NATURE REVIEWS CARDIOLOGY (2011)
Applications of post-translational modifications of FoxO family proteins in biological functions
Ying Zhao et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2011)
Validation of high-resolution echocardiography and magnetic resonance imaging vs. high-fidelity catheterization in experimental pulmonary hypertension
Dalia Urboniene et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2010)
A comparison of echocardiography to invasive measurement in the evaluation of pulmonary arterial hypertension in a rat model
Juha W. Koskenvuo et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2010)
Discovery of Novel Forkhead Box O1 Inhibitors for Treating Type 2 Diabetes: Improvement of Fasting Glycemia in Diabetic db/db Mice
Takeyuki Nagashima et al.
MOLECULAR PHARMACOLOGY (2010)
Targeting non-malignant disorders with tyrosine kinase inhibitors
Friedrich Grimminger et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall
Maria G. Frid et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2009)
Connective Tissue Disease-associated Pulmonary Arterial Hypertension in the Modern Treatment Era
Robin Condliffe et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Mitochondrial metabolism, redox signaling, and fusion:: a mitochondria-ROS-HIF-1α-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer
Stephen L. Archer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Role of the prostanoid EP4 receptor in iloprost-mediated vasodilatation in pulmonary hypertension
Ying-Ju Lai et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
The involvement of FOXO1 in cytotoxic stress and drug-resistance induced by paclitaxel in ovarian cancers
T. Goto et al.
BRITISH JOURNAL OF CANCER (2008)
Molecular pathogenesis of pulmonary arterial hypertension
Marlene Rabinovitch
JOURNAL OF CLINICAL INVESTIGATION (2008)
FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis
Ji-Hye Paik et al.
CELL (2007)
Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange
Norbert Weissmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
FOXOs in the maintenance of vascular homoeostasis
J-H Paik
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
Sildenafil citrate therapy for pulmonary arterial hypertension
N Galiè et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Reversal of experimental pulmonary hypertension by PDGF inhibition
RT Schermuly et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Imatinib for the treatment of pulmonary arterial hypertension
HA Ghofrani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis and improves survival in rats with pulmonary hypertension
SL Merklinger et al.
CIRCULATION (2005)
The psammaplysenes, specific inhibitors of FOXO1a nuclear export
FC Schroeder et al.
JOURNAL OF NATURAL PRODUCTS (2005)
Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification
T Hosaka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation
LP van der Heide et al.
BIOCHEMICAL JOURNAL (2004)
Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice:: cooperativity of Ink4a/ARF and Trp53 loss of function
C Keller et al.
GENES & DEVELOPMENT (2004)
FoxOs at the crossroads of cellular metabolism, differentiation, and transformation
D Accili et al.
CELL (2004)
A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells
TR Kau et al.
CANCER CELL (2003)
Inflammation in pulmonary arterial hypertension
P Dorfmüller et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Inhaled iloprost for severe pulmonary hypertension
H Olschewski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Janus face of vascular endothelial growth factor: The obligatory survival factor for lung vascular endothelium controls precapillary artery remodeling in severe pulmonary hypertension
NF Voelkel et al.
CRITICAL CARE MEDICINE (2002)
Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor
C Atkinson et al.
CIRCULATION (2002)
Bosentan therapy for pulmonary arterial hypertension
LJ Rubin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
cDNA array hybridization after laser-assisted microdissection from nonneoplastic tissue
L Fink et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension
L Taraseviciene-Stewart et al.
FASEB JOURNAL (2001)
Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene
ZM Deng et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
Share Paper
